0      0

LV011 - New Drug Updates: Investigational Therapeutics in the Pipeline

‐ Nov 11, 2023 4:45pm


Sandra Cuellar reports that she receives honoraria for serving on speaker bureaus from Mirati and Genentech.

Learning Objectives:

  • Identify new investigational therapeutic agents currently being evaluated in the hematology/oncology pipeline.
  • Describe the pharmacology of novel investigational therapeutics currently under development.
  • Discuss literature supporting the ongoing evaluation of emerging therapeutic agents.


You must be logged in and own this session in order to post comments.